MedPath

辽宁美滋林药业有限公司

Ownership
-
Established
2002-06-14
Employees
-
Market Cap
-
Website
http://www.lnmzlyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Sodium Hyaluronate Eye Drops

Product Name
玻璃酸钠滴眼液
Approval Number
国药准字H20183088
Approval Date
Apr 7, 2023
NMPA

Bromfenac Sodium Eye Drops

Product Name
溴芬酸钠滴眼液
Approval Number
国药准字H20193244
Approval Date
Aug 29, 2019
NMPA

Ozagrel Sodium for Injection

Product Name
注射用奥扎格雷钠
Approval Number
国药准字H20093105
Approval Date
Dec 25, 2013
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20084043
Approval Date
Aug 19, 2013
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.